Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study.

Li CT, Chen LF, Tu PC, Wang SJ, Chen MH, Su TP, Hsieh JC.

PLoS One. 2013 Aug 2;8(8):e70089. doi: 10.1371/journal.pone.0070089. Print 2013.

2.

Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.

Paillère Martinot ML, Galinowski A, Ringuenet D, Gallarda T, Lefaucheur JP, Bellivier F, Picq C, Bruguière P, Mangin JF, Rivière D, Willer JC, Falissard B, Leboyer M, Olié JP, Artiges E, Martinot JL.

Int J Neuropsychopharmacol. 2010 Feb;13(1):45-59. doi: 10.1017/S146114570900008X. Epub 2009 Mar 9.

PMID:
19267956
3.

Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response.

Pallanti S, Di Rollo A, Antonini S, Cauli G, Hollander E, Quercioli L.

Neuropsychobiology. 2012 Jun;65(4):227-35. doi: 10.1159/000336999. Epub 2012 May 25.

PMID:
22653158
4.

The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.

Baeken C, Marinazzo D, Everaert H, Wu GR, Van Hove C, Audenaert K, Goethals I, De Vos F, Peremans K, De Raedt R.

Brain Stimul. 2015 Jul-Aug;8(4):808-15. doi: 10.1016/j.brs.2015.01.415. Epub 2015 Feb 7.

PMID:
25744500
5.

Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS.

Richieri R, Boyer L, Padovani R, Adida M, Colavolpe C, Mundler O, Lançon C, Guedj E.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):364-70. doi: 10.1016/j.pnpbp.2012.07.012. Epub 2012 Jul 29.

PMID:
22850205
6.

Prefrontal cortical blood flow predicts response of depression to rTMS.

Weiduschat N, Dubin MJ.

J Affect Disord. 2013 Sep 5;150(2):699-702. doi: 10.1016/j.jad.2013.04.049. Epub 2013 May 22.

PMID:
23707032
7.

HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging.

Baeken C, De Raedt R, Van Hove C, Clerinx P, De Mey J, Bossuyt A.

CNS Spectr. 2009 Aug;14(8):439-48.

PMID:
19890238
8.

Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity.

Baeken C, Marinazzo D, Wu GR, Van Schuerbeek P, De Mey J, Marchetti I, Vanderhasselt MA, Remue J, Luypaert R, De Raedt R.

World J Biol Psychiatry. 2014 May;15(4):286-97. doi: 10.3109/15622975.2013.872295. Epub 2014 Jan 21.

PMID:
24447053
9.

Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.

Paillère Martinot ML, Martinot JL, Ringuenet D, Galinowski A, Gallarda T, Bellivier F, Lefaucheur JP, Lemaitre H, Artiges E.

Neuropsychopharmacology. 2011 Dec;36(13):2710-9. doi: 10.1038/npp.2011.161. Epub 2011 Aug 17.

10.

High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression.

Garcia-Toro M, Salva J, Daumal J, Andres J, Romera M, Lafau O, Echevarría M, Mestre M, Bosch C, Collado C, Ibarra O, Aguirre I.

Psychiatry Res. 2006 Jan 30;146(1):53-7. Epub 2005 Dec 13.

PMID:
16356697
11.

Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.

Speer AM, Kimbrell TA, Wassermann EM, D Repella J, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2000 Dec 15;48(12):1133-41.

PMID:
11137053
12.

[Repetitive transcranial magnetic stimulation in major depression: response factor].

Dumas R, Padovani R, Richieri R, Lançon C.

Encephale. 2012 Sep;38(4):360-8. doi: 10.1016/j.encep.2011.08.004. Epub 2011 Oct 11. Review. French.

PMID:
22980479
13.

Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients.

Baeken C, Vanderhasselt MA, Remue J, Herremans S, Vanderbruggen N, Zeeuws D, Santermans L, De Raedt R.

J Affect Disord. 2013 Nov;151(2):625-31. doi: 10.1016/j.jad.2013.07.008. Epub 2013 Jul 26.

PMID:
23896317
14.

Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.

McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS.

Depress Anxiety. 2011 Nov;28(11):973-80. doi: 10.1002/da.20885. Epub 2011 Sep 2.

15.

The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT.

Brunelin J, Jalenques I, Trojak B, Attal J, Szekely D, Gay A, Januel D, Haffen E, Schott-Pethelaz AM, Brault C; STEP Group, Poulet E.

Brain Stimul. 2014 Nov-Dec;7(6):855-63. doi: 10.1016/j.brs.2014.07.040. Epub 2014 Aug 7.

PMID:
25192980
16.

Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).

Langguth B, Wiegand R, Kharraz A, Landgrebe M, Marienhagen J, Frick U, Hajak G, Eichhammer P.

Neuro Endocrinol Lett. 2007 Oct;28(5):633-8.

PMID:
17984932
17.

A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.

Fitzgerald PB, Hoy K, Gunewardene R, Slack C, Ibrahim S, Bailey M, Daskalakis ZJ.

Psychol Med. 2011 Jun;41(6):1187-96. doi: 10.1017/S0033291710001923. Epub 2010 Oct 7.

PMID:
20925972
18.

Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers.

Kimbrell TA, Dunn RT, George MS, Danielson AL, Willis MW, Repella JD, Benson BE, Herscovitch P, Post RM, Wassermann EM.

Psychiatry Res. 2002 Oct 1;115(3):101-13.

PMID:
12208488
19.

rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex.

Cardoso EF, Fregni F, Martins Maia F, Boggio PS, Luis Myczkowski M, Coracini K, Lopes Vieira A, Melo LM, Sato JR, Antonio Marcolin M, Rigonatti SP, Cruz AC Jr, Reis Barbosa E, Amaro E Jr.

Int J Neuropsychopharmacol. 2008 Mar;11(2):173-83. Epub 2007 Aug 21.

PMID:
17708780
20.
Items per page

Supplemental Content

Write to the Help Desk